Isolation And Characterisation Of Novel Progenitor Cells In The Mammary Epithelium And Their Role During Carcinogenesis.
Funder
National Health and Medical Research Council
Funding Amount
$470,346.00
Summary
Stem and progenitor cells in the breast are the immature cells from which mature cells are derived. Their are long-lived, resistant to death and can produce multiple types of mature cells, implicating them as cells from which breast cancer may originate. We aim to search for novel cell surface markers that define the progenitor cells in the mouse mammary gland. The data gathered from this project may facilitate the development of targeted therapies to the cells of origin in breast cancer.
Identifying Resistance Mechanisms Of Targeted BRAF Inhibitors In Metastatic Melanoma
Funder
National Health and Medical Research Council
Funding Amount
$379,015.00
Summary
Late-stage melanoma is an aggressive skin cancer for which traditional treatment strategies such as chemotherapy are ineffective. Recently, a new class of targeted drugs (BRAF inhibitors) has become the standard of care for a subset of melanoma patients; however, long term treatment success is complicated by drug resistance. This study will identify the causes of resistance with the purpose to improve targeted drug strategies and increase survival rates for late-stage melanoma patients.